BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19182210)

  • 1. Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis.
    Pendino F; Nguyen E; Jonassen I; Dysvik B; Azouz A; Lanotte M; Ségal-Bendirdjian E; Lillehaug JR
    Blood; 2009 Apr; 113(14):3172-81. PubMed ID: 19182210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemia.
    Astori A; Fredly H; Aloysius TA; Bullinger L; Mansat-De Mas V; de la Grange P; Delhommeau F; Hagen KM; Récher C; Dusanter-Fourt I; Knappskog S; Lillehaug JR; Pendino F; Bruserud Ø
    Oncotarget; 2013 Sep; 4(9):1438-48. PubMed ID: 23988457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epigenetic regulator RINF (CXXC5) maintains
    Astori A; Matherat G; Munoz I; Gautier EF; Surdez D; Zermati Y; Verdier F; Zaidi S; Feuillet V; Kadi A; Lauret E; Delattre O; Lefèvre C; Fontenay M; Ségal-Bendirdjian E; Dusanter-Fourt I; Bouscary D; Hermine O; Mayeux P; Pendino F
    Haematologica; 2022 Jan; 107(1):268-283. PubMed ID: 33241676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation.
    Bruserud Ø; Reikvam H; Fredly H; Skavland J; Hagen KM; van Hoang TT; Brenner AK; Kadi A; Astori A; Gjertsen BT; Pendino F
    Oncotarget; 2015 Feb; 6(5):2794-811. PubMed ID: 25605239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster.
    Zhang X; Lian Z; Padden C; Gerstein MB; Rozowsky J; Snyder M; Gingeras TR; Kapranov P; Weissman SM; Newburger PE
    Blood; 2009 Mar; 113(11):2526-34. PubMed ID: 19144990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer.
    Knappskog S; Myklebust LM; Busch C; Aloysius T; Varhaug JE; Lønning PE; Lillehaug JR; Pendino F
    Ann Oncol; 2011 Oct; 22(10):2208-15. PubMed ID: 21325450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontline Science: Cxxc5 expression alters cell cycle and myeloid differentiation of mouse hematopoietic stem and progenitor cells.
    Joshi HR; Hill HR; Zhou Z; He X; Voelkerding KV; Kumánovics A
    J Leukoc Biol; 2020 Aug; 108(2):469-484. PubMed ID: 32083332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays.
    Park DJ; Vuong PT; de Vos S; Douer D; Koeffler HP
    Blood; 2003 Nov; 102(10):3727-36. PubMed ID: 12893766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.
    Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of a novel retinoid-inducible gene 1(RIG1) deriving from human gastric cancer cells.
    Huang SL; Shyu RY; Yeh MY; Jiang SY
    Mol Cell Endocrinol; 2000 Jan; 159(1-2):15-24. PubMed ID: 10687848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of UBE1L in ISG15 conjugation during retinoid-induced differentiation of acute promyelocytic leukemia.
    Pitha-Rowe I; Hassel BA; Dmitrovsky E
    J Biol Chem; 2004 Apr; 279(18):18178-87. PubMed ID: 14976209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoid-induced growth arrest of breast carcinoma cells involves co-activation of multiple growth-inhibitory genes.
    Dokmanovic M; Chang BD; Fang J; Roninson IB
    Cancer Biol Ther; 2002; 1(1):24-7. PubMed ID: 12170760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid signaling in myelopoiesis.
    Drumea K; Yang ZF; Rosmarin A
    Curr Opin Hematol; 2008 Jan; 15(1):37-41. PubMed ID: 18043244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
    Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
    Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study.
    Shen L; Zhu J; Chen F; Lin W; Cai J; Zhong J; Zhong H
    BMC Cancer; 2015 Dec; 15():970. PubMed ID: 26674644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties.
    Pandolfi PP; Grignani F; Alcalay M; Mencarelli A; Biondi A; LoCoco F; Grignani F; Pelicci PG
    Oncogene; 1991 Jul; 6(7):1285-92. PubMed ID: 1650447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic expression during human myelopoiesis.
    Ferrari F; Bortoluzzi S; Coppe A; Basso D; Bicciato S; Zini R; Gemelli C; Danieli GA; Ferrari S
    BMC Genomics; 2007 Aug; 8():264. PubMed ID: 17683550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment.
    Park DJ; Chumakov AM; Vuong PT; Chih DY; Gombart AF; Miller WH; Koeffler HP
    J Clin Invest; 1999 May; 103(10):1399-408. PubMed ID: 10330422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiation.
    Mainardi S; Pelosi A; Palescandolo E; Riccioni R; Fontemaggi G; Diverio D; Testa U; Sacchi A; Grignani F; Lo-Coco F; Levrero M; Blandino G; Rizzo MG
    Cell Death Differ; 2007 Nov; 14(11):1968-71. PubMed ID: 17690711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.